Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Janssen Pharmaceutica (Resolor Development And Marketing Rights)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A portfolio of development and marketing right for prucalopride. The asset is mainly used for treatment of chronic constipation.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Acquirer
Primary Office
  • Belgium

Janssen Pharmaceutica (Resolor Development And Marketing Rights) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Janssen Pharmaceutica (Resolor Development And Marketing Rights)‘s full profile, request access.

Request full access to PitchBook

Janssen Pharmaceutica (Resolor Development And Marketing Rights) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Janssen Pharmaceutica (Resolor Development And Marketing Rights)‘s full profile, request access.

Request full access to PitchBook